MEDICO REMEDIES LIMITED

Other languages Medico Remedies Limited

Equities

MEDICO

INE630Y01024

Delayed Bombay S.E. Other stock markets 01:11:57 2024-06-07 EDT			5-day change	1st Jan Change
38 ^INR	+3.54%		+2.98%	-54.54%

05-09	Medico Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
05-09	Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medico Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-09
Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-09
Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12
Medico Remedies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09
Medico Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Medico Remedies Limited Completes Trial Production Round At the Newly Established State of the Art Ointment Manufacturing Plant At Palghar	23-05-13
Medico Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-11
Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10
Medico Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12
Medico Remedies Limited Announces Appointment of Deepesh Shah as an Additional Independent Director	22-04-22
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-12
Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-05-27
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer